Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,579 INR | +2.15% | -3.61% | +81.30% |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 614.8 | 644.5 | 571.6 | 1,231 | 2,656 | 2,342 |
Enterprise Value (EV) 1 | 618.5 | 626.1 | 545.5 | 920 | 2,292 | 2,117 |
P/E ratio | 41.8 x | 15.3 x | 8.16 x | 10.4 x | 16.1 x | 26.6 x |
Yield | 0.55% | 0.53% | 0.82% | 1.38% | 0.64% | 0.72% |
Capitalization / Revenue | 2.76 x | 1.42 x | 0.91 x | 1.54 x | 2.7 x | 3.9 x |
EV / Revenue | 2.77 x | 1.37 x | 0.87 x | 1.15 x | 2.33 x | 3.53 x |
EV / EBITDA | 22.6 x | 9.56 x | 5.4 x | 6.06 x | 11.2 x | 19 x |
EV / FCF | -23.2 x | 13.4 x | 4.77 x | 11.7 x | 23.3 x | -59.1 x |
FCF Yield | -4.31% | 7.45% | 21% | 8.55% | 4.3% | -1.69% |
Price to Book | 1.42 x | 1.39 x | 1.08 x | 1.92 x | 3.41 x | 2.74 x |
Nbr of stocks (in thousands) | 4,240 | 4,240 | 4,240 | 4,240 | 4,240 | 4,240 |
Reference price 2 | 145.0 | 152.0 | 134.8 | 290.4 | 626.4 | 552.3 |
Announcement Date | 8/7/18 | 8/26/19 | 9/3/20 | 9/8/21 | 9/5/22 | 9/5/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 222.9 | 455.4 | 627.7 | 797.4 | 984.4 | 600.1 |
EBITDA 1 | 27.34 | 65.52 | 101 | 151.9 | 205.2 | 111.3 |
EBIT 1 | 20.21 | 57.88 | 92.65 | 143.5 | 196.9 | 103.5 |
Operating Margin | 9.06% | 12.71% | 14.76% | 17.99% | 20% | 17.25% |
Earnings before Tax (EBT) 1 | 19.38 | 58.97 | 91.45 | 157.4 | 222.6 | 121.5 |
Net income 1 | 14.72 | 41.99 | 70.01 | 118.4 | 165.4 | 87.89 |
Net margin | 6.6% | 9.22% | 11.15% | 14.85% | 16.8% | 14.65% |
EPS 2 | 3.471 | 9.903 | 16.51 | 27.93 | 39.01 | 20.73 |
Free Cash Flow 1 | -26.69 | 46.62 | 114.4 | 78.64 | 98.58 | -35.84 |
FCF margin | -11.97% | 10.24% | 18.22% | 9.86% | 10.01% | -5.97% |
FCF Conversion (EBITDA) | - | 71.16% | 113.22% | 51.77% | 48.03% | - |
FCF Conversion (Net income) | - | 111.03% | 163.35% | 66.4% | 59.6% | - |
Dividend per Share 2 | 0.8000 | 0.8000 | 1.100 | 4.000 | 4.000 | 4.000 |
Announcement Date | 8/7/18 | 8/26/19 | 9/3/20 | 9/8/21 | 9/5/22 | 9/5/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 3.65 | - | - | - | - | - |
Net Cash position 1 | - | 18.4 | 26.1 | 311 | 364 | 225 |
Leverage (Debt/EBITDA) | 0.1336 x | - | - | - | - | - |
Free Cash Flow 1 | -26.7 | 46.6 | 114 | 78.6 | 98.6 | -35.8 |
ROE (net income / shareholders' equity) | 3.36% | 9.2% | 13.9% | 20.1% | 23.1% | 10.7% |
ROA (Net income/ Total Assets) | 2.52% | 6.34% | 8.65% | 11.9% | 13.8% | 6.41% |
Assets 1 | 585 | 662.1 | 809.1 | 993.8 | 1,203 | 1,371 |
Book Value Per Share 2 | 102.0 | 110.0 | 124.0 | 151.0 | 184.0 | 201.0 |
Cash Flow per Share 2 | 1.110 | 3.920 | 4.200 | 1.980 | 2.480 | 2.060 |
Capex 1 | 7.27 | 15.1 | 7.18 | 4.21 | 0.67 | 5.93 |
Capex / Sales | 3.26% | 3.31% | 1.14% | 0.53% | 0.07% | 0.99% |
Announcement Date | 8/7/18 | 8/26/19 | 9/3/20 | 9/8/21 | 9/5/22 | 9/5/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+81.30% | 131M | |
+28.13% | 143B | |
+15.44% | 82.11B | |
-3.71% | 66.71B | |
+25.35% | 53.3B | |
+51.28% | 48.25B | |
+6.75% | 42.65B | |
+77.38% | 39.86B | |
+60.84% | 25.93B | |
+83.90% | 24.85B |
- Stock Market
- Equities
- SIKA6 Stock
- Financials Sika Interplant Systems Limited